Toggle light / dark theme

Scientists have captured new images of a calcium-shuttling molecule that has been linked to aggressive cancers. The three-dimensional structure could help researchers develop novel therapies and diagnostic tools for diseases that are caused by a malfunction in calcium adsorption.

Alexander Sobolevsky’s lab at Columbia University Medical Center is studying a family of proteins called “Transient receptor potential (TRP)” channels. These proteins line surfaces inside the body, such as the intestine, and form pores that help calcium cross a dense barrier of lipid and protein called the membrane to reach the interior of the cell.

“Scientists have found that a TRP channel variant, called TRPV6, is present in excess amounts in the tumor cells of some cancer patients,” says senior author Alexander Sobolevsky, PhD, who is an assistant professor in the Department of Biochemistry and Molecular Biophysics at Columbia University Medical Center. “And patients who have higher quantities of TRPV6 seem to have a more aggressive form of the disease.”

Read more

Matthew Davis’ Arcus is officially the most impressive thing we’ve ever seen come out of a 3D printer. Sure, cheap prosthetics and replacement body parts are important uses of the technology, but this spinning rubber band blaster is what finally makes us want to put a 3D printer on our desks.

Unlike most rubber band blasters that only fire a single shot every time you squeeze the trigger or require a drive mechanism to make them fully automatic, Davis’ Arcus uses the energy from the loaded elastics to spin the barrel and automatically fire shot after shot until it’s empty. Brilliant.

Read more

There is a well-documented organ shortage throughout the world. For example, 3,000 kidney transplants were made last year in the United Kingdom, but that still left 5,000 people on the waiting list at the end of the period. A lucrative trade in organs has grown up, and transplant tourism has become relatively common. While politicians wring their hands about sensible solutions to the shortage, including the nudge of opt-out donation, scientists using genetic manipulations have been making significant progress in growing transplantable organs inside pigs.

Scientists in the United States are creating so-called ‘human-pig chimeras’ which will be capable of growing the much-needed organs. These chimeras are animals that combine human and pig characteristics. They are like mules that will provide organs that can be transplanted into humans. A mule is the offspring of a male donkey (jack) and a female horse (mare). Horses and donkeys are different species with different numbers of chromosomes, but they can breed together.

In this case, the scientists take a skin cell from a human and from this make stem cells capable of producing any cell or tissue in the body, known as ‘induced pluripotent stem cells’. They then inject these into a pig embryo to make a human-pig chimera. In order to create the desired organ, they use gene editing, or CRISPR, to knock out the embryo’s pig’s genes that produce, for example, the pancreas. The human stem cells for the pancreas then make an almost entirely human pancreas in the resulting human-pig chimera, with just the blood vessels remaining porcine. Using this controversial technology, a human skin cell, pre-treated and injected into a genetically edited pig embryo, could grow a new liver, heart, pancreas or lung as required.

Read more

A POSSIBLE cure for inherited eye diseases which cause blindness is within sight thanks to a breakthrough recorded by a Tasmanian-led research team.

Associate Professor Alex Hewitt, an ophthalmologist and a researcher with the University of Tasmania’s Menzies Institute for Medical Research and the School of Medicine, said his team had successfully edited adult eye tissue genes in the laboratory to replace unwanted genes that caused blindness.

Dr Hewitt said he was optimistic Tasmanian doctors could soon start wielding molecular gene shears inside the eyes of humans.

Read more

High-performance detectors that are compatible with mainstream semiconductor device fabrication deliver high speed, ultra-sensitivity, and good timing resolution.

Recent advances in biomedical imaging include the enhancement of image contrast, 3D sectioning capability, and compatibility with specialized imaging modes such as fluorescence lifetime imaging (FLIM).1–3 Compared with other imaging methods, FLIM offers the highest image contrast because it measures the lifetime of the fluorescence, rather than just its intensity or wavelength characteristics. The contrasting fluorescence lifetime attributes can then enable the observer to discriminate between regions, such as identifying healthy and diseased tissue for cancer detection. In conventional FLIM, a discrete single-photon detector, typically based on photomultiplier tube (PMT) technology, enables the acquisition of a single focal spot.4 This focal spot is then raster-scanned across the field of view to form an image. This approach, however, requires sequential scanning—pixel by pixel—and thus results in a slow image acquisition rate.

Read more

An illustration showing how the “window to the brain” transparent skull implant created by UC Riverside researchers would work (credit: UC Riverside)

Researchers at the University of California, Riverside have developed a transparent “window to the brain” — a skull implant that is biocompatible, infection-resistant, and does not need to be repetitively replaced.

Part of the ongoing “Window to the Brain” project, a multi-institution, cross-disciplinary effort, the idea is to use transparent skull implants to provide laser diagnosis and treatment of a wide variety of brain pathologies, including brain cancers, traumatic brain injury, stroke, and neurodegenerative diseases, without requiring repeated craniotomies (a surgical operation in which a bone flap is temporarily removed from the skull to access the brain). Such operations are vulnerable to bacterial infections.

A biocompatible transparent material

The researchers have developed a transparent version of the material yttria-stabilized zirconia (YSZ), a ceramic material used in hip implants and dental crowns.

If you are interested in the work of SENS and how Dr Haroldo Silva and his team are looking for ways to treat cancer why not come along and join them?


There is going to be a SENS AMA on Reddit with Aubrey de Grey and OncoSENS researcher Haroldo Silva. Ask them anything about SENS and the long term goal of developing universal cancer therapies.

FUTUROLOGY JULY 19TH 1 pm EST/10 am PST/6 pm BST.

Read more

Ready for the strange? Here you go.


If you aren’t already purchasing organic or GMO-free rice, you should be. Rice that has been engineered with actual human genes is on its way to a supermarket near you. In Junction City, Kansas, this human gene-tainted rice is being grown on 3,200 acres by the biotechnology company Ventria Bioscience.

Ventria began cultivating this rather horrifying product in 2006 with human liver genes. What exactly was the purpose of this, you ask? Their intention was to harvest the artificial enzymes produced by the rice and use them in pharmaceuticals. Ventria has taken one of the most widely grown and consumed crops and turned it into the base for new prescription drugs — all with USDA approval, of course.

Their decision to allow plants intended for pharmaceuticals to be grown outdoors has not gone without protest. Ventria initially wanted to plant their “crops” — if you can call them that anymore — in Missouri. However, they were met with staunch opposition from Anheuser-Busch and others, who promptly threatened to boycott all rice from the state if the biotechnology planted their GMO rice within the state’s borders. Eventually though, Ventria found a place to settle in Kansas. In 2007, Jane Rissler from the Union of Concerned Scientists (UCS) told the Washington Post, “It is unwise to produce drugs in plants outdoors.”